Press Releases

Theralink’s RPPA (Reverse Phase Protein Array) Technology to be deployed to support and enhance Genomic insights and may ultima...

Denver, Colorado — March 21, 2022 — Theralink Technologies (OTC: THER) (“Theralink” or the “Company”), a precision med...

Denver, Colorado — March 14, 2022 — Theralink Technologies (OTC: THER) (“Theralink” or the “Company”), a precision onc...

DENVER, February 24, 2022 -- Theralink® Technologies - (OTC: THER) ("Theralink" or the "Company"), announces today that it has...

DENVER, October. 22, 2021 -- Theralink® Technologies - (OTC: OBMP) ("Theralink" or the "Company"), a precision medicine molecu...

DENVER, March. 29, 2021 -- Theralink® Technologies - (OTC: OBMP) ("Theralink" or the "Company"), a precision medicine and mol...

DENVER, Feb. 22, 2021 -- Theralink® Technologies - (OTC: OBMP) ("Theralink" or the "Company"),  In a recent announcement by R...

DENVER, Jan. 27, 2021 -- Theralink® Technologies - (OTC: OBMP) ("Theralink" or the "Company"), a precision medicine molecular...

DENVER, Colorado — January 6, 2021 —Theralink Technologies (OTC: OBMP) (“Theralink” or the “Company”), a molecular pro...

DENVER, Colorado — November 16, 2020 —Theralink Technologies (OTC: OBMP) (“Theralink” or the “Company”), a precision o...